Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
Johnson and Johnson
Mallinckrodt
Medtronic
Merck

Last Updated: October 22, 2019

DrugPatentWatch Database Preview

Elan Pharm Company Profile

See Plans and Pricing

« Back to Dashboard

Summary for Elan Pharm
Patents:73
Tradenames:1
Ingredients:1
BLAs:1
Patent Litigation for Elan Pharm: See patent lawsuits for Elan Pharm

US Patents for Elan Pharm

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Elan Pharm MYOBLOC botulinum toxin type b VIAL 103846 001 2000-12-08 9,782,492 Allergan, Inc. (Irvine, CA) 2029-12-18 RX search
Elan Pharm MYOBLOC botulinum toxin type b VIAL 103846 001 2000-12-08 9,447,401 Halozyme, Inc. (San Diego, CA) 2031-12-30 RX search
Elan Pharm MYOBLOC botulinum toxin type b VIAL 103846 001 2000-12-08 9,409,997 Nanotech Biomachines, Inc. (Berkeley, CA) 2033-05-24 RX search
Elan Pharm MYOBLOC botulinum toxin type b VIAL 103846 001 2000-12-08 9,402,910 Nanotech Biomachines, Inc. (Berkeley, CA) 2033-07-12 RX search
Elan Pharm MYOBLOC botulinum toxin type b VIAL 103846 001 2000-12-08 9,238,061 Allergan, Inc. (Irvine, CA) 2023-10-29 RX search
Elan Pharm MYOBLOC botulinum toxin type b VIAL 103846 001 2000-12-08 9,078,892 Allergan, Inc. (Irvine, CA) 2039-03-29 RX search
Elan Pharm MYOBLOC botulinum toxin type b VIAL 103846 001 2000-12-08 9,056,059 Allergan, Inc. (Irvine, CA) 2024-10-01 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
Boehringer Ingelheim
Harvard Business School
Dow
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.